You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

Alvogen Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ALVOGEN, and what generic and branded alternatives to ALVOGEN drugs are available?

ALVOGEN has fifty-seven approved drugs.

There are two tentative approvals on ALVOGEN drugs.

Summary for Alvogen

US Patents:	0
Tradenames:	47
Ingredients:	45
NDAs:	57
Patent Litigation for Alvogen:	See patent lawsuits for Alvogen
PTAB Cases with Alvogen as petitioner:	See PTAB cases with Alvogen as petitioner

Drugs and US Patents for Alvogen

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alvogen	LIDEX-E	fluocinonide	CREAM;TOPICAL	016908-003	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Alvogen	BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE	buprenorphine hydrochloride; naloxone hydrochloride	FILM;BUCCAL, SUBLINGUAL	205954-004	Jan 24, 2019	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Alvogen	BONSITY	teriparatide	SOLUTION;SUBCUTANEOUS	211939-001	Oct 4, 2019		RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Alvogen	PREGABALIN	pregabalin	TABLET, EXTENDED RELEASE;ORAL	211687-001	Jul 6, 2021		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Alvogen	NEVIRAPINE	nevirapine	TABLET, EXTENDED RELEASE;ORAL	204621-001	Jul 10, 2015		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Alvogen	RIVASTIGMINE	rivastigmine	FILM, EXTENDED RELEASE;TRANSDERMAL	204403-003	Aug 31, 2015	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Alvogen

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alvogen	TRANDATE	labetalol hydrochloride	TABLET;ORAL	018716-003	Aug 1, 1984	4,012,444	⤷ Try a Trial
Alvogen	TRANDATE	labetalol hydrochloride	TABLET;ORAL	018716-002	Aug 1, 1984	4,066,755	⤷ Try a Trial
Alvogen	TAMBOCOR	flecainide acetate	TABLET;ORAL	018830-004	Aug 23, 1988	4,005,209	⤷ Try a Trial
Alvogen	LIDEX	fluocinonide	OINTMENT;TOPICAL	016909-002	Approved Prior to Jan 1, 1982	4,017,615	⤷ Try a Trial
Alvogen	SPECTAZOLE	econazole nitrate	CREAM;TOPICAL	018751-001	Dec 23, 1982	3,717,655	⤷ Try a Trial
Alvogen	TRANDATE	labetalol hydrochloride	TABLET;ORAL	018716-003	Aug 1, 1984	4,066,755	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.